Shopping Cart 0
Cart Subtotal
AED 0

Pharmaceuticals in France

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 1285

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 2569

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 3854
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Pharmaceuticals in France

 

Summary

 

Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

 

Key Highlights

 

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The French pharmaceuticals market had total revenues of USD 37.4m in 2018, representing a compound annual growth rate (CAGR) of 0% between 2014 and 2018.

- The performance of the market is forecast to decline, with an anticipated compound annual rate of change (CARC) of -0.7% for the five-year period 2018-2023, which is expected to drive the market to a value of USD 36.1m by the end of 2023.

- A renewed focus on value within the French pharma market has brought about a decline in overall market value.

 

Scope

 

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in France

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in France

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts

 

Reasons to buy

 

- What was the size of the France pharmaceuticals market by value in 2018?

- What will be the size of the France pharmaceuticals market in 2023?

- What factors are affecting the strength of competition in the France pharmaceuticals market?

- How has the market performed over the last five years?

- How large is France's pharmaceuticals market in relation to its regional counterparts?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary

Market value

Market value forecast

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Geography segmentation

Market share

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

AstraZeneca PLC

Laboratoires Pierre Fabre SA

Sanofi SA

Les Laboratoires Servier

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

List of Figures

Figure 1: France pharmaceuticals market value: USD billion, 2014-18

Figure 2: France pharmaceuticals market geography segmentation: % share, by value, 2018

Figure 3: France pharmaceuticals market share: % share, by value, 2018

Figure 4: France pharmaceuticals market value forecast: USD billion, 2018-23

Figure 5: Forces driving competition in the pharmaceuticals market in France, 2018

Figure 6: Drivers of buyer power in the pharmaceuticals market in France, 2018

Figure 7: Drivers of supplier power in the pharmaceuticals market in France, 2018

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2018

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2018

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in France, 2018

Figure 11: AstraZeneca PLC: revenues & profitability

Figure 12: AstraZeneca PLC: assets & liabilities

Figure 13: Sanofi SA: revenues & profitability

Figure 14: Sanofi SA: assets & liabilities


List Of Table

List of Tables

Table 1: France pharmaceuticals market value: USD billion, 2014-18

Table 2: France pharmaceuticals market geography segmentation: USD billion, 2018

Table 3: France pharmaceuticals market share: % share, by value, 2018

Table 4: France pharmaceuticals market value forecast: USD billion, 2018-23

Table 5: AstraZeneca PLC: key facts

Table 6: AstraZeneca PLC: key financials (USD )

Table 7: AstraZeneca PLC: key financial ratios

Table 8: Laboratoires Pierre Fabre SA: key facts

Table 9: Sanofi SA: key facts

Table 10: Sanofi SA: key financials (USD )

Table 11: Sanofi SA: key financials (EUR)

Table 12: Sanofi SA: key financial ratios

Table 13: Les Laboratoires Servier: key facts

Table 14: France size of population (million), 2014-18

Table 15: France gdp (constant 2005 prices, USD billion), 2014-18

Table 16: France gdp (current prices, USD billion), 2014-18

Table 17: France inflation, 2014-18

Table 18: France consumer price index (absolute), 2014-18

Table 19: France exchange rate, 2014-18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

AstraZeneca PLC

Laboratoires Pierre Fabre SA

Sanofi SA

Les Laboratoires Servier

Pharmaceuticals in France

 

Summary

 

Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

 

Key Highlights

 

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The French pharmaceuticals market had total revenues of USD 37.4m in 2018, representing a compound annual growth rate (CAGR) of 0% between 2014 and 2018.

- The performance of the market is forecast to decline, with an anticipated compound annual rate of change (CARC) of -0.7% for the five-year period 2018-2023, which is expected to drive the market to a value of USD 36.1m by the end of 2023.

- A renewed focus on value within the French pharma market has brought about a decline in overall market value.

 

Scope

 

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in France

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in France

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts

 

Reasons to buy

 

- What was the size of the France pharmaceuticals market by value in 2018?

- What will be the size of the France pharmaceuticals market in 2023?

- What factors are affecting the strength of competition in the France pharmaceuticals market?

- How has the market performed over the last five years?

- How large is France's pharmaceuticals market in relation to its regional counterparts?

READ MORE

Scope

Table of Contents

Executive Summary

Market value

Market value forecast

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Geography segmentation

Market share

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

AstraZeneca PLC

Laboratoires Pierre Fabre SA

Sanofi SA

Les Laboratoires Servier

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

List of Figures

Figure 1: France pharmaceuticals market value: USD billion, 2014-18

Figure 2: France pharmaceuticals market geography segmentation: % share, by value, 2018

Figure 3: France pharmaceuticals market share: % share, by value, 2018

Figure 4: France pharmaceuticals market value forecast: USD billion, 2018-23

Figure 5: Forces driving competition in the pharmaceuticals market in France, 2018

Figure 6: Drivers of buyer power in the pharmaceuticals market in France, 2018

Figure 7: Drivers of supplier power in the pharmaceuticals market in France, 2018

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2018

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2018

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in France, 2018

Figure 11: AstraZeneca PLC: revenues & profitability

Figure 12: AstraZeneca PLC: assets & liabilities

Figure 13: Sanofi SA: revenues & profitability

Figure 14: Sanofi SA: assets & liabilities


List Of Table

List of Tables

Table 1: France pharmaceuticals market value: USD billion, 2014-18

Table 2: France pharmaceuticals market geography segmentation: USD billion, 2018

Table 3: France pharmaceuticals market share: % share, by value, 2018

Table 4: France pharmaceuticals market value forecast: USD billion, 2018-23

Table 5: AstraZeneca PLC: key facts

Table 6: AstraZeneca PLC: key financials (USD )

Table 7: AstraZeneca PLC: key financial ratios

Table 8: Laboratoires Pierre Fabre SA: key facts

Table 9: Sanofi SA: key facts

Table 10: Sanofi SA: key financials (USD )

Table 11: Sanofi SA: key financials (EUR)

Table 12: Sanofi SA: key financial ratios

Table 13: Les Laboratoires Servier: key facts

Table 14: France size of population (million), 2014-18

Table 15: France gdp (constant 2005 prices, USD billion), 2014-18

Table 16: France gdp (current prices, USD billion), 2014-18

Table 17: France inflation, 2014-18

Table 18: France consumer price index (absolute), 2014-18

Table 19: France exchange rate, 2014-18

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

AstraZeneca PLC

Laboratoires Pierre Fabre SA

Sanofi SA

Les Laboratoires Servier